Overview
Comprehensive Parasitology x2 (Culture, PCR + Parasitology) examines the composition of intestinal bacteria, yeast and parasites through a combined approach of stool culture, PCR analysis and microscopic examination. By analysing two stool samples collected on different days, the profile broadens the scope of microbial assessment, capturing organisms that might intermittently appear. The test results provide insight into the balance of commensal bacteria, yeast populations and potential microbial imbalances, alongside the identification of cultured species where antimicrobial response patterns may be observed.
This collection of analyses supports a broader understanding of digestive wellness and microbial diversity, exploring factors that may influence nutrient absorption, gut comfort and general vitality. Observing variations in bacterial and yeast presence as well as parasitic elements helps to identify trends that relate to overall gastrointestinal environment and wellbeing. The integration of culture, PCR and parasitology methods offers a comprehensive view to support wellbeing-oriented applications and lifestyle considerations.
Interpreting the results typically involves consideration of personal lifestyle aspects such as diet, travel history, recent medication or supplement intake and other wellness-related observations. Using two samples increases the reliability of detecting fluctuating microorganisms and enriches the context for individual assessment. This approach aims to inform personal optimisation and awareness regarding the gut microbiome and its potential effects on general health maintenance.
Comprehensive Parasitology x2 (Culture, PCR + Parasitology) is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Comprehensive Parasitology x2 (Culture, PCR + Parasitology) is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.
Practical
Downloads
03-Jun-2024
03-Jun-2024
03-Jun-2024
03-Jun-2024
03-Jun-2024